Résultats de la recherche

search

Rechercher les filtres

Mot-clé
cardiology
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program
19 mars 2025 08h01 HE | Stereotaxis, Inc.
ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA...
Lungpacer Announces IDE for STARI Clinical Study
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
10 mars 2025 07h00 HE | Lungpacer Medical USA Inc.
Lungpacer Medical is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S. FDA for the STARI clinical study.
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance
03 mars 2025 07h31 HE | Stereotaxis, Inc.
ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA...
Heartflow Unveils Bold New Vision for Management of Coronary Artery Disease
25 févr. 2025 08h00 HE | HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the global leader in AI technology for coronary artery disease (CAD) management, today introduced its new brand identity...
George Medicines Logo.JPG
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs
03 févr. 2025 07h00 HE | George Medicines
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs London, UK, 3 February 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing...
Stereotaxis Logo - New Tagline - Black Text.png
Stereotaxis Announces First GenesisX Robotic System Order
30 janv. 2025 08h09 HE | Stereotaxis, Inc.
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has...
Stereotaxis Logo - New Tagline - Black Text.png
Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology
14 janv. 2025 07h21 HE | Stereotaxis, Inc.
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
LOGO Updated.png
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
13 janv. 2025 08h00 HE | SS Innovations
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
George Medicines Logo.JPG
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central America
13 janv. 2025 07h00 HE | George Medicines
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Colombia and Central AmericaBausch Health gains exclusive rights to single-pill triple...
TRiCare.png
TRiCares Announces First Topaz Implantations in US Early Feasibility Study
09 janv. 2025 03h30 HE | TRiCares SAS
Paris, France and Munich, Germany, January 09, 2025 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid valve that flexes with every heartbeat, announces that the first...